• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二吡酮代谢物 4-氨基安替比林作为大麻素受体 1 激动剂的计算分析。

Computational Analysis of Dipyrone Metabolite 4-Aminoantipyrine As A Cannabinoid Receptor 1 Agonist.

机构信息

Laboratory of Computational Systems Biology, School of Sciences - Pontifical Catholic University of Rio Grande do Sul (PUCRS), Av. Ipiranga, 6681, Porto Alegre-RS 90619-900, Brazil.

出版信息

Curr Med Chem. 2020;27(28):4741-4749. doi: 10.2174/0929867326666190906155339.

DOI:10.2174/0929867326666190906155339
PMID:31490743
Abstract

BACKGROUND

Cannabinoid receptor 1 has its crystallographic structure available in complex with agonists and inverse agonists, which paved the way to establish an understanding of the structural basis of interactions with ligands. Dipyrone is a prodrug with analgesic capabilities and is widely used in some countries. Recently some evidence of a dipyrone metabolite acting over the Cannabinoid Receptor 1has been shown.

OBJECTIVE

Our goal here is to explore the dipyrone metabolite 4-aminoantipyrine as a Cannabinoid Receptor 1 agonist, reviewing dipyrone characteristics, and investigating the structural basis for its interaction with the Cannabinoid Receptor 1.

METHOD

We reviewed here recent functional studies related to the dipyrone metabolite focusing on its action as a Cannabinoid Receptor 1 agonist. We also analyzed protein-ligand interactions for this complex obtained through docking simulations against the crystallographic structure of the Cannabinoid Receptor 1.

RESULTS

Analysis of the crystallographic structure and docking simulations revealed that most of the interactions present in the docked pose were also present in the crystallographic structure of Cannabinoid Receptor 1 and agonist.

CONCLUSION

Analysis of the complex of 4-aminoantipyrine and Cannabinoid Receptor 1 revealed the pivotal role played by residues Phe 170, Phe 174, Phe 177, Phe 189, Leu 193, Val 196, and Phe 379, besides the conserved hydrogen bond at Ser 383. The mechanistic analysis and the present computational study suggest that the dipyrone metabolite 4-aminoantipyrine interacts with the Cannabinoid Receptor 1.

摘要

背景

大麻素受体 1 与其激动剂和反向激动剂的晶体结构已经确定,这为理解与配体相互作用的结构基础铺平了道路。双氯芬酸是一种具有镇痛作用的前药,在一些国家被广泛使用。最近有证据表明双氯芬酸的一种代谢物作用于大麻素受体 1。

目的

我们的目标是探索双氯芬酸的代谢物 4-氨基安替比林作为大麻素受体 1 的激动剂,回顾双氯芬酸的特性,并研究其与大麻素受体 1 相互作用的结构基础。

方法

我们在这里回顾了最近与双氯芬酸代谢物相关的功能研究,重点关注其作为大麻素受体 1 激动剂的作用。我们还分析了通过对接模拟获得的该复合物与大麻素受体 1 的晶体结构之间的蛋白质-配体相互作用。

结果

晶体结构分析和对接模拟表明,对接构象中存在的大多数相互作用也存在于大麻素受体 1 和激动剂的晶体结构中。

结论

对 4-氨基安替比林和大麻素受体 1 复合物的分析揭示了残基 Phe 170、Phe 174、Phe 177、Phe 189、Leu 193、Val 196 和 Phe 379 以及 Ser 383 处保守氢键所起的关键作用。机制分析和本计算研究表明,双氯芬酸的代谢物 4-氨基安替比林与大麻素受体 1 相互作用。

相似文献

1
Computational Analysis of Dipyrone Metabolite 4-Aminoantipyrine As A Cannabinoid Receptor 1 Agonist.二吡酮代谢物 4-氨基安替比林作为大麻素受体 1 激动剂的计算分析。
Curr Med Chem. 2020;27(28):4741-4749. doi: 10.2174/0929867326666190906155339.
2
Advances in the Understanding of the Cannabinoid Receptor 1 - Focusing on the Inverse Agonists Interactions.大麻素受体 1 的研究进展 - 聚焦于反向激动剂的相互作用。
Curr Med Chem. 2019;26(10):1908-1919. doi: 10.2174/0929867325666180417165247.
3
The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: neuronal K(ATP) channel opening and CB(1) receptor activation.安乃近在外周组织中的镇痛作用涉及两种不同机制:神经元ATP敏感性钾通道开放和CB1受体激活。
Eur J Pharmacol. 2014 Oct 15;741:124-31. doi: 10.1016/j.ejphar.2014.07.019. Epub 2014 Jul 21.
4
Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.CB1大麻素受体的同源模型:非经典大麻素激动剂相互作用的关键位点
Biopolymers. 2003;71(2):169-89. doi: 10.1002/bip.10424.
5
Human Cannabinoid Receptor 2 Ligand-Interaction Motif: Transmembrane Helix 2 Cysteine, C2.59(89), as Determinant of Classical Cannabinoid Agonist Activity and Binding Pose.人源大麻素受体2配体相互作用基序:跨膜螺旋2半胱氨酸,C2.59(89),作为经典大麻素激动剂活性和结合构象的决定因素。
ACS Chem Neurosci. 2017 Jun 21;8(6):1338-1347. doi: 10.1021/acschemneuro.7b00003. Epub 2017 Mar 1.
6
Novel bioactive metabolites of dipyrone (metamizol).新型吡罗昔康(灭痛定)生物活性代谢产物。
Bioorg Med Chem. 2012 Jan 1;20(1):101-7. doi: 10.1016/j.bmc.2011.11.028. Epub 2011 Nov 25.
7
Pharmacokinetic properties of metamizole active metabolites in Northeastern Brazilian donkeys (Equus asinus).巴西东北部驴(Equus asinus)中甲灭酸活性代谢物的药代动力学特性。
J Vet Pharmacol Ther. 2021 Sep;44(5):842-849. doi: 10.1111/jvp.12998. Epub 2021 Jul 15.
8
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.大麻素在疼痛管理中的应用:CB1、CB2 和非经典受体配体。
Expert Opin Investig Drugs. 2014 Aug;23(8):1123-40. doi: 10.1517/13543784.2014.918603. Epub 2014 May 16.
9
Cannabinoid CB1 receptors mediate the effects of dipyrone.大麻素CB1受体介导安乃近的作用。
Clin Exp Pharmacol Physiol. 2015 Mar;42(3):246-55. doi: 10.1111/1440-1681.12347.
10
Pharmacokinetic profiles of the two major active metabolites of metamizole (dipyrone) in cats following three different routes of administration.安乃近(双氯芬酸钠)的两种主要活性代谢产物在猫体内经三种不同给药途径后的药代动力学特征。
J Vet Pharmacol Ther. 2018 Apr;41(2):334-339. doi: 10.1111/jvp.12471. Epub 2017 Nov 21.

引用本文的文献

1
Non-opioid Analgesics and the Endocannabinoid System.非阿片类镇痛药与内源性大麻素系统。
Balkan Med J. 2020 Oct 23;37(6):309-315. doi: 10.4274/balkanmedj.galenos.2020.2020.6.66. Epub 2020 Jun 19.